Brent crude oil exceeded $73/barrel, up 1.57% in the day.*ST Zhongli: The company's reorganization plan was approved by the court. *ST Zhongli announced that the company's reorganization plan had been approved by the Suzhou Intermediate People's Court and the reorganization procedure was terminated. The content of the reorganization plan is consistent with the previously disclosed draft, aiming at comprehensively solving the historical problems of the company's 1.805 billion yuan capital occupation and illegal guarantee. In the implementation stage of the reorganization plan, the company will be responsible for implementation and the manager will be responsible for supervision. If it is successfully implemented, it will help to optimize the company's asset-liability structure, enhance its sustainable operation and profitability, and have a significant impact on the relevant financial indicators in 2024.Huichuan Technology: Small-load six-axis robots have been sold in large quantities, and large-load six-axis robots have begun to be sold in large quantities. Huichuan Technology said on the interactive platform that the company has greatly expanded the products and applications of six-axis robots, and the small-load six-axis robots have been sold in large quantities, and the large-load six-axis robots have begun to form mass sales.
Modern Investment: Xu Qing, the independent director of the company, was subject to disciplinary review and supervision investigation. According to the announcement of Modern Investment, Xu Qing, the independent director of the company, was suspected of serious violation of discipline and law, and is currently subject to disciplinary review by the Disciplinary Committee of Hunan Branch of Industrial and Commercial Bank of China and supervision investigation by Zhuzhou Municipal Supervision Committee. Xu Qing did not hold any other positions in the company except as an independent director, chairman of the Nomination Committee of the Board of Directors, member of the Strategy Committee of the Board of Directors and member of the Audit Committee of the Board of Directors, and did not participate in the daily operation and management of the company. The company will pay attention to the subsequent progress and fulfill its information disclosure obligations in a timely manner in strict accordance with relevant regulations.Light Media: "Nezha's Devil's Boy Makes a Sea" has rich derivatives planning. Light Media said on the interactive platform that at present, the company's IP derivative business is advancing normally. "Nezha's Devil Kids Roaring the Sea" has been planned and will launch derivative products with rich categories and wide price range in due course, including tide play, handcrafted products, statues, cards, stationery, food play, badges, billboards, publications, plush products and daily necessities, which can meet the diverse needs of different groups of people.MONDELEZ's share price rose 2.5% before the market, and it was authorized to buy back $9 billion in the news.
MONDELEZ's share price rose 2.5% before the market, and it was authorized to buy back $9 billion in the news.The first super-kilometer tunnel in the Kangyu section of the Xi 'an-Chongqing high-speed railway runs through, and the construction of the Xi 'an-Chongqing high-speed railway (referred to as "Xi 'an-Chongqing high-speed railway") will spread new news. On December 10th, it was learned from Tiexikun Company of Beijing-Kunming High-speed Railway that after 620 days of construction, Wangjiabang Tunnel of Xiyu High-speed Railway in Qianfeng District of Guang 'an City was completed, four months ahead of the design period. This is the first tunnel of more than 1,000 meters in the Kangyu section of the Xi-Yu high-speed railway, marking another breakthrough in the construction of the Xi-Yu high-speed railway.The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)
Strategy guide
12-14
Strategy guide